Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

Lycopene inhibits disease progression in patients with benign prostate hyperplasia.

Schwarz S, Obermüller-Jevic UC, Hellmis E, Koch W, Jacobi G, Biesalski HK.

J Nutr. 2008 Jan;138(1):49-53.

PMID:
18156403
2.

Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy.

Kucuk O, Sarkar FH, Sakr W, Djuric Z, Pollak MN, Khachik F, Li YW, Banerjee M, Grignon D, Bertram JS, Crissman JD, Pontes EJ, Wood DP Jr.

Cancer Epidemiol Biomarkers Prev. 2001 Aug;10(8):861-8.

3.

Effects of lycopene supplementation in patients with localized prostate cancer.

Kucuk O, Sarkar FH, Djuric Z, Sakr W, Pollak MN, Khachik F, Banerjee M, Bertram JS, Wood DP Jr.

Exp Biol Med (Maywood). 2002 Nov;227(10):881-5.

PMID:
12424329
4.

Tomato lycopene extract supplementation decreases insulin-like growth factor-I levels in colon cancer patients.

Walfisch S, Walfisch Y, Kirilov E, Linde N, Mnitentag H, Agbaria R, Sharoni Y, Levy J.

Eur J Cancer Prev. 2007 Aug;16(4):298-303.

PMID:
17554202
5.

Lycopene and soy isoflavones in the treatment of prostate cancer.

Vaishampayan U, Hussain M, Banerjee M, Seren S, Sarkar FH, Fontana J, Forman JD, Cher ML, Powell I, Pontes JE, Kucuk O.

Nutr Cancer. 2007;59(1):1-7.

PMID:
17927495
6.

Effect of lycopene supplementation on insulin-like growth factor-1 and insulin-like growth factor binding protein-3: a double-blind, placebo-controlled trial.

Graydon R, Gilchrist SE, Young IS, Obermüller-Jevic U, Hasselwander O, Woodside JV.

Eur J Clin Nutr. 2007 Oct;61(10):1196-200. Epub 2007 Feb 7.

PMID:
17299493
7.

A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk.

Bunker CH, McDonald AC, Evans RW, de la Rosa N, Boumosleh JM, Patrick AL.

Nutr Cancer. 2007;57(2):130-7.

PMID:
17571945
8.

Is there a benefit from lycopene supplementation in men with prostate cancer? A systematic review.

Haseen F, Cantwell MM, O'Sullivan JM, Murray LJ.

Prostate Cancer Prostatic Dis. 2009;12(4):325-32. doi: 10.1038/pcan.2009.38. Epub 2009 Sep 1. Review.

PMID:
19901932
9.

Lycopene for the prevention and treatment of benign prostatic hyperplasia and prostate cancer: a systematic review.

Ilic D, Misso M.

Maturitas. 2012 Aug;72(4):269-76. doi: 10.1016/j.maturitas.2012.04.014. Epub 2012 May 23. Review.

PMID:
22633187
10.

The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study.

Roehrborn CG, Siami P, Barkin J, Damião R, Becher E, Miñana B, Mirone V, Castro R, Wilson T, Montorsi F; CombAT Study Group.

Eur Urol. 2009 Feb;55(2):461-71. doi: 10.1016/j.eururo.2008.10.037. Epub 2008 Nov 6.

PMID:
19013011
11.

BXL628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia: a randomized clinical trial.

Colli E, Rigatti P, Montorsi F, Artibani W, Petta S, Mondaini N, Scarpa R, Usai P, Olivieri L, Maggi M; BPH Italian study group.

Eur Urol. 2006 Jan;49(1):82-6. Epub 2005 Nov 15.

PMID:
16310924
12.

Lycopene supplementation elevates circulating insulin-like growth factor binding protein-1 and -2 concentrations in persons at greater risk of colorectal cancer.

Vrieling A, Voskuil DW, Bonfrer JM, Korse CM, van Doorn J, Cats A, Depla AC, Timmer R, Witteman BJ, van Leeuwen FE, Van't Veer LJ, Rookus MA, Kampman E.

Am J Clin Nutr. 2007 Nov;86(5):1456-62.

PMID:
17991659
13.

Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men.

Liu CC, Huang SP, Li WM, Wang CJ, Chou YH, Li CC, Huang CH, Wu WJ.

Urology. 2007 Oct;70(4):677-80.

PMID:
17991536
14.

A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?

Gontero P, Marra G, Soria F, Oderda M, Zitella A, Baratta F, Chiorino G, Gregnanin I, Daniele L, Cattel L, Frea B, Brusa P.

Prostate. 2015 Aug 1;75(11):1177-86. doi: 10.1002/pros.22999. Epub 2015 Apr 20.

PMID:
25893930
15.

Effects of tomato sauce consumption on apoptotic cell death in prostate benign hyperplasia and carcinoma.

Kim HS, Bowen P, Chen L, Duncan C, Ghosh L, Sharifi R, Christov K.

Nutr Cancer. 2003;47(1):40-7.

PMID:
14769536
16.

[Correlation of benign prostatic hyperplasia with hyperlipemia].

Li PJ, Zhang XH, Guo LJ, Na YQ.

Zhonghua Wai Ke Za Zhi. 2005 Mar 15;43(6):387-9. Chinese.

PMID:
15854349
17.
18.
19.

How do intermediate endpoint markers respond to lycopene in men with prostate cancer or benign prostate hyperplasia?

van Breemen RB.

J Nutr. 2005 Aug;135(8):2062S-4S. No abstract available.

PMID:
16046743
20.

Differential effects of lycopene consumed in tomato paste and lycopene in the form of a purified extract on target genes of cancer prostatic cells.

Talvas J, Caris-Veyrat C, Guy L, Rambeau M, Lyan B, Minet-Quinard R, Lobaccaro JM, Vasson MP, Georgé S, Mazur A, Rock E.

Am J Clin Nutr. 2010 Jun;91(6):1716-24. doi: 10.3945/ajcn.2009.28666. Epub 2010 Apr 14.

PMID:
20392890

Supplemental Content

Support Center